Page not found

• 
• 
• 
• 

Search results

1. VUMC to test whether Alzheimer’s drug can ease lupus symptoms

   10/10/2022 Vanderbilt University Medical Center is partnering with  ... five clinical trials, including the memantine study. In July 2022, VUMC announced its intention to  collaborate  with a not-for-profit ... MBA. “The limited success in the repurposing world to date demonstrates that the findings generated via these predictive models must ...

   sommers - 10/10/2022 - 4:24pm

2. Study takes personal approach to cochlear implant programming

   ... “Dr. Wilkerson, our center’s founder, dreamed that one day deaf children could communicate verbally,” said Roland Eavey, MD, Guy M. ...

   sommers - 03/05/2019 - 9:34am

3. Ancora Innovations - Request for Applications on Rare Genetics Diseases Opening January 2021

   12/18/2020 ...

   sommers - 12/19/2020 - 11:33am

4. Vanderbilt University anti-inflammatory therapy licensed to Amytrx is now in clinical trials for eczema treatment

   10/29/2020 A cell-penetrating, anti-inflammatory peptide ... for mild to moderate eczema. The peptide, known as AMTX-100, has been in clinical trials since March.  The licensing agreement, ...

   sommers - 10/30/2020 - 12:45pm

5. Ancora Innovation Announces Second RFP Process March 14

   02/20/2019 ...

   sommers - 03/14/2019 - 1:09pm

6. Designing antibodies to fight the flu

   02/06/2019 ...

   sommers - 02/21/2019 - 9:51am

7. Insulin accelerant

   10/23/2018 ...

   sommers - 02/21/2019 - 9:51am

8. Cellular stress defense

   10/23/2018 ...

   sommers - 02/21/2019 - 9:51am

9. Targeting diabetic kidney disease

   10/23/2018 Diabetic nephropathy (DN) is a kidney ... factor receptor (EGFR) is activated in mouse models of type 1 diabetes, and that drugs which inhibit EGFR prevent the development of DN. ...

   sommers - 02/21/2019 - 9:51am

10. “These could revolutionize the world” — Pint cracks code to cheap, small carbon nanotubes

    05/24/2018 ...

    sommers - 05/25/2018 - 2:00pm